A Review of Retrospective Study of Psoriasis Existing and Advances in Treatment

B. Sri Tulasi*, SK. Meharunnisa
Ratnam Institute of Pharmacy, Pidthapolur (V), Muthukur (M), Nellore (Dt), Andhra Pradesh – 524343, India.
DOI: https://doi.org/10.30904/j.ijmpr.2024.4587
Int. J. Med. Pharm. Res., 2024, 12(1): 01-04

A B S T R A C T
Psoriasis is a common skin condition that affects approximately 2-3% of the population. It is characterized by red patches with white scales and is caused by chronic inflammation and excessive skin cell growth. Psoriasis is a disease that can significantly impact various aspects of a person’s professional and social life. Fortunately, several treatments are available to help control psoriasis such as methotrexate, cyclosporin, oral retinoids, and phototherapy. The existing treatments for psoriasis can only relieve the symptoms and improve the lives of individuals. However, recent advancements in our understanding of psoriasis have led to the discovering of new immunological factors and pathways. This has opened the possibility of developing new biological drugs targeting specific immunological elements responsible for causing psoriasis. Biological drugs are less toxic and more effective than traditional therapies, which should improve the quality of life of patients with psoriasis. This review discusses existing and advanced psoriasis treatments currently in clinical trials or on the market and used to treat moderate-to-severe plaque psoriasis.
Keywords: psoriasis, specific immunological elements, traditional therapies, plaque psoriasis.